CervoMed
CRVO
12 hedge funds and large institutions have $1.25M invested in CervoMed in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
0.13% less ownership
Funds ownership: 0.32% → 0.19% (-0.13%)
14% less funds holding
Funds holding: 14 → 12 (-2)
46% less capital invested
Capital invested by funds: $2.32M → $1.25M (-$1.07M)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$72.5K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$11.6K |
| 3 |
Morgan Stanley
New York
|
+$1.61K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$161 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$427K |
| 2 |
Renaissance Technologies
New York
|
-$34.6K |
| 3 |
VF
Virtu Financial
New York
|
-$34K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.61K |
| 5 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$933 |
CRVO Hedge Fund Activity: Q3 2019 in Review
12 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q3 2019, worth a combined $1.25M — down 46% from $2.32M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of CRVO and 2 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 2 added.
The largest buyer was Vanguard Group, adding an estimated $72.5K. The largest seller was Wells Fargo, exiting entirely with an estimated $427K sold.
- 12 institutional investors held CervoMed (CRVO) as of Q3 2019, down from 14 in Q2 2019.
- Funds reported $1.25M of CervoMed stock for Q3 2019, down 46% quarter-over-quarter.
- 2 funds opened new CervoMed positions in Q3 2019 and 4 closed out, a net change of -2 holders.
- The largest CervoMed buyer in Q3 2019 was Vanguard Group, an estimated $72.5K added.
- The largest CervoMed seller in Q3 2019 was Wells Fargo, an estimated $427K sold.
Based on aggregated 13F filings for Q3 2019.